---
title: "Analysts Offer Insights on Healthcare Companies: Polynovo (OtherCALZF), Clinuvel Pharmaceuticals (OtherCLVLF) and Impedimed Limited (OtherIPDQF)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/297270766.md"
description: "Analysts Offer Insights on Healthcare Companies: Polynovo (OtherCALZF), Clinuvel Pharmaceuticals (OtherCLVLF) and Impedimed Limited (OtherIPDQF)"
datetime: "2026-08-28T05:45:13.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/297270766.md)
  - [en](https://longbridge.com/en/news/297270766.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/297270766.md)
generator: "portal-rs"
---

# Analysts Offer Insights on Healthcare Companies: Polynovo (OtherCALZF), Clinuvel Pharmaceuticals (OtherCLVLF) and Impedimed Limited (OtherIPDQF)


### Related Stocks

- [CUVL.US](https://longbridge.com/en/quote/CUVL.US.md)
- [IPD.AU](https://longbridge.com/en/quote/IPD.AU.md)
- [PNV.AU](https://longbridge.com/en/quote/PNV.AU.md)
- [CUV.AU](https://longbridge.com/en/quote/CUV.AU.md)

## Related News & Research

- [Morgans Sticks to Their Buy Rating for Polynovo  (CALZF)](https://longbridge.com/en/news/297119663.md)
- [Clinuvel posts FY2026 net profit after tax of A$34 million, cash reserves rise to A$252 million](https://longbridge.com/en/news/297115070.md)
- [CUV: Profit streak continues with robust cash reserves and stable dividend, supporting U.S. growth](https://longbridge.com/en/news/297114798.md)
- [Bell Potter Reaffirms Their Buy Rating on Neuren Pharmaceuticals Limited (NURPF)](https://longbridge.com/en/news/297151708.md)
- [Glenmark Pharmaceuticals Limited (NSE:GLENMARK) Looks Like A Good Stock, And It's Going Ex-Dividend Soon](https://longbridge.com/en/news/297101432.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**